SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Consensus Rating of “Buy” from Analysts

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have issued a report on the […]

Leave a Reply

Your email address will not be published.

Previous post Comparing Alvotech (NASDAQ:ALVO) & Fresh Tracks Therapeutics (NASDAQ:FRTX)
Next post Canoo Inc. (NASDAQ:GOEV) Receives $23.79 Consensus Price Target from Brokerages